Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0829320090120030144
Korean Journal of Clinical Microbiology
2009 Volume.12 No. 3 p.144 ~ p.145
Evaluation of the Vitek 2 AST-N055 Card for the Susceptibility Testing of Acinetobacter baumannii Isolates to Amikacin
Park Dong-Jin

Song Won-Keun
Kim Taek-Kyung
Kim Jae-Seok
Kim Han-Sung
Lee Kyu-Man
Abstract
We collected 76 clinical isolates of Acinetobacter baumannii (amikacin MIC by Vitek 2 AST-N055 card: ¡Â2¥ìg/mL, 11 isolates; 4¥ìg/mL, 19 isolates; 8¥ìg/ mL, 17 isolates; 16¥ìg/mL, 27 isolates; and ¡Ã64¥ìg/ mL, 2 isolates) from a university hospital and evaluated the Vitek 2 AST-N055 card vs the broth microdilution as a reference method for testing susceptibility to amikacin. Vitek 2 AST-N055 card yielded very major errors in 15 isolates (19.7%) and minor errors in 26 isolates (34.2%). Of the 15 isolates shown very major errors, 14 had Vitek 2 MICs ranging from 8 to 16¥ìg/mL. The results of our study suggest strongly that it is unreliable to test the amikacin susceptibility by Vitek 2 AST-N055 card of A. baumannii with the Vitek 2 MICs ranging from 8 to 16¥ìg/mL. In those cases, another susceptibility test, such as broth microdilution (BMD), should be performed to confirm the results.
KEYWORD
Amikacin, Acinetobacter baumannii, Vitek 2
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø